
People with Long COVID May Still Have Spike Proteins in Their Blood
A possible biomarker for long COVID suggests some people with the condition never fully cleared the virus
A possible biomarker for long COVID suggests some people with the condition never fully cleared the virus
People who are unlikely to develop severe COVID-19 have no widely approved medications to ease the illness
Nanotubes may provide a cunning answer to the mystery of how the virus that causes COVID infects neurons and produces long-lasting neurological symptoms
A technique that detects coronavirus strains circulating in a community could become an early-warning system
The FDA has called for updating COVID vaccines to address the Omicron subvariants BA.4 and BA.5. But will the shots keep up with the virus?
Scientists in Thailand have established that a tabby passed SARS-CoV-2 to a veterinary surgeon—although such cases of cat-to-human transmission are probably rare
The model, which uses machine learning to track the fitness of different viral strains, accurately predicted the rise of Omicron’s BA.2 subvariant and the Alpha variant
An advisory committee voted unanimously to recommend authorizing the Moderna and Pfizer shots for the youngest children
Upgrading buildings’ ventilation, filtration and other factors would not only decrease COVID transmission but also improve health and cognitive performance in general
The death rate among unvaccinated people is still far higher than that among the vaccinated even though vaccinated people now make up a significant proportion of deaths
Results from a large study suggest that vaccines offer less protection against lingering symptoms than expected
Experts address when the youngest children could be eligible for the shots, why that has taken so long, and more
Two testing experts explain the latest data on how well the assays perform
Some over-the-counter medications can help symptoms, and there are ways to ease isolation
Patient history, context and a few symptoms may help distinguish between the conditions
How to tell the different versions of SARS-CoV-2 apart, and how well vaccines protect against them
Scientific American asks experts in medicine, risk assessment and other fields how to balance the risks of COVID with the benefits of visiting public indoor spaces
Does the new strain sweeping the globe mean COVID will become ever more contagious?
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs
Saliva PCR tests may detect disease earlier in the course of an infection
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account